Physics Bucharest 2017

Conventional or Hypofractionated High Dose Intensity Modulated Radiotherapy for Prostate Cancer (CHHiP) Trial Design

T1B – T3A N0 M0 Estimated risk of seminal vesicle involvement ≤ 30% PSA ≤ 30ng/ml

Recruitment >3000 patients

Randomisation

Group 1 74Gy / 37#

Group 2 60Gy / 20#

Group 3 57Gy / 19 #